BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28437839)

  • 1. Inhibition of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 reduces lipopolysaccharide-induced neuroinflammation.
    Becchi S; Buson A; Foot J; Jarolimek W; Balleine BW
    Br J Pharmacol; 2017 Jul; 174(14):2302-2317. PubMed ID: 28437839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of vascular adhesion protein 1 protects dopamine neurons from the effects of acute inflammation and restores habit learning in the striatum.
    Becchi S; Buson A; Balleine BW
    J Neuroinflammation; 2021 Oct; 18(1):233. PubMed ID: 34654450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PXS-4681A, a potent and selective mechanism-based inhibitor of SSAO/VAP-1 with anti-inflammatory effects in vivo.
    Foot JS; Yow TT; Schilter H; Buson A; Deodhar M; Findlay AD; Guo L; McDonald IA; Turner CI; Zhou W; Jarolimek W
    J Pharmacol Exp Ther; 2013 Nov; 347(2):365-74. PubMed ID: 23943052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of an anti-inflammatory VAP-1/SSAO inhibitor, PXS-4728A, on pulmonary neutrophil migration.
    Schilter HC; Collison A; Russo RC; Foot JS; Yow TT; Vieira AT; Tavares LD; Mattes J; Teixeira MM; Jarolimek W
    Respir Res; 2015 Mar; 16(1):42. PubMed ID: 25889951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin blocks soluble SSAO/VAP-1 release in experimental models of cerebral ischemia: Possible benefits for stroke-induced inflammation control.
    Sun P; Hernandez-Guillamón M; Campos-Martorell M; Simats A; Montaner J; Unzeta M; Solé M
    Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):542-553. PubMed ID: 29175057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory effects of inhibiting the amine oxidase activity of semicarbazide-sensitive amine oxidase.
    Salter-Cid LM; Wang E; O'Rourke AM; Miller A; Gao H; Huang L; Garcia A; Linnik MD
    J Pharmacol Exp Ther; 2005 Nov; 315(2):553-62. PubMed ID: 16081681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory effects of LJP 1586 [Z-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride], an amine-based inhibitor of semicarbazide-sensitive amine oxidase activity.
    O'Rourke AM; Wang EY; Miller A; Podar EM; Scheyhing K; Huang L; Kessler C; Gao H; Ton-Nu HT; Macdonald MT; Jones DS; Linnik MD
    J Pharmacol Exp Ther; 2008 Feb; 324(2):867-75. PubMed ID: 17993604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of semicarbazide-sensitive amine oxidase reduces atherosclerosis in apolipoprotein E-deficient mice.
    Wang SH; Yu TY; Tsai FC; Weston CJ; Lin MS; Hung CS; Kao HL; Li YI; Solé M; Unzeta M; Chen YL; Chuang LM; Li HY
    Transl Res; 2018 Jul; 197():12-31. PubMed ID: 29653075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glitazones inhibit human monoamine oxidase but their anti-inflammatory actions are not mediated by VAP-1/semicarbazide-sensitive amine oxidase inhibition.
    Carpéné C; Bizou M; Tréguer K; Hasnaoui M; Grès S
    J Physiol Biochem; 2015 Sep; 71(3):487-96. PubMed ID: 25572340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The discovery and development of selective 3-fluoro-4-aryloxyallylamine inhibitors of the amine oxidase activity of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 (SSAO/VAP-1).
    Foot JS; Deodhar M; Turner CI; Yin P; van Dam EM; Silva DG; Olivieri A; Holt A; McDonald IA
    Bioorg Med Chem Lett; 2012 Jun; 22(12):3935-40. PubMed ID: 22595173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Semicarbazide-sensitive Amine Oxidase Reduces Atherosclerosis in Cholesterol-fed New Zealand White Rabbits.
    Wang SH; Yu TY; Hung CS; Yang CY; Lin MS; Su CY; Chen YL; Kao HL; Chuang LM; Tsai FC; Li HY
    Sci Rep; 2018 Jun; 8(1):9249. PubMed ID: 29915377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1: a patent survey.
    Dunkel P; Balogh B; Meleddu R; Maccioni E; Gyires K; Mátyus P
    Expert Opin Ther Pat; 2011 Sep; 21(9):1453-71. PubMed ID: 21675926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble Vascular Adhesion Protein-1 Mediates Spermine Oxidation as Semicarbazide-Sensitive Amine Oxidase: Possible Role in Proliferative Diabetic Retinopathy.
    Murata M; Noda K; Kawasaki A; Yoshida S; Dong Y; Saito M; Dong Z; Ando R; Mori S; Saito W; Kanda A; Ishida S
    Curr Eye Res; 2017 Dec; 42(12):1674-1683. PubMed ID: 28937866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular adhesion protein-1 regulates leukocyte transmigration rate in the retina during diabetes.
    Noda K; Nakao S; Zandi S; Engelstädter V; Mashima Y; Hafezi-Moghadam A
    Exp Eye Res; 2009 Nov; 89(5):774-81. PubMed ID: 19635478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular adhesion protein-1 (VAP-1) in vascular inflammatory diseases.
    Danielli M; Thomas RC; Quinn LM; Tan BK
    Vasa; 2022 Nov; 51(6):341-350. PubMed ID: 36200383
    [No Abstract]   [Full Text] [Related]  

  • 16. Benzylamine and methylamine, substrates of semicarbazide-sensitive amine oxidase, attenuate inflammatory response induced by lipopolysaccharide.
    Lin Z; Li H; Luo H; Zhang Y; Luo W
    Int Immunopharmacol; 2011 Aug; 11(8):1079-89. PubMed ID: 21414430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood-brain barrier dysfunction underlying Alzheimer's disease is induced by an SSAO/VAP-1-dependent cerebrovascular activation with enhanced Aβ deposition.
    Solé M; Esteban-Lopez M; Taltavull B; Fábregas C; Fadó R; Casals N; Rodríguez-Álvarez J; Miñano-Molina AJ; Unzeta M
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2189-2202. PubMed ID: 31047972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibitor of semicarbazide-sensitive amine oxidase, PXS-4728A, ameliorates key features of chronic obstructive pulmonary disease in a mouse model.
    Jarnicki AG; Schilter H; Liu G; Wheeldon K; Essilfie AT; Foot JS; Yow TT; Jarolimek W; Hansbro PM
    Br J Pharmacol; 2016 Nov; 173(22):3161-3175. PubMed ID: 27495192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of the multitarget compound DPH-4 on human SSAO/VAP-1-expressing hCMEC/D3 cells under oxygen-glucose deprivation conditions: an in vitro experimental model of cerebral ischaemia.
    Sun P; Esteban G; Inokuchi T; Marco-Contelles J; Weksler BB; Romero IA; Couraud PO; Unzeta M; Solé M
    Br J Pharmacol; 2015 Nov; 172(22):5390-402. PubMed ID: 26362823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular adhesion protein-1 plays an important role in postischemic inflammation and neuropathology in diabetic, estrogen-treated ovariectomized female rats subjected to transient forebrain ischemia.
    Xu HL; Salter-Cid L; Linnik MD; Wang EY; Paisansathan C; Pelligrino DA
    J Pharmacol Exp Ther; 2006 Apr; 317(1):19-29. PubMed ID: 16339390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.